Skip to main content
Michigan OPEN

Novel Psychoactive Substances: Clinical Realities and Emerging Risks

Partnerships, Virtual
Jun 2, 2025

WHEN: Monday, June 2nd from 12:00 PM – 1:00 PM EST

WHERE: Zoom. Register here(link is external)

Objectives

  • Identify the emerging psychoactive substances of 2025.
  • Utilize clinical clues to identify intoxication from emerging psychoactive substances.
  • Discuss clinical challenges posed by novel psychoactive substances.

CME & CE Information

This activity has been approved for 1.0 Social Work and AMA PRA Category 1 Credit™.

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Michigan Medical School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Michigan Psychiatry Department is an approved provider with the Michigan Social Work Continuing Education Collaborative to sponsor continuing education for social workers for 1.0 CE Clock Hours. Approved Provider Number for social work: MICEC-0063.

For CE and other information, contact Teresa Vogel: tvogel@med.umich.edu(link sends e-mail)

Description and Expected Results

Bimonthly, University of Michigan Addiction Treatment Services (UMATS) will host a lecture and discussion to inform and enhance clinical practice through the exploration of topics related to the etiology, prevention, and treatment of problematic substance use and substance use disorders. This will bring together individuals from research and clinical areas to foster multi-disciplinary discussion and learning related to substance use disorders, the latest research evidence, and clinical best-practices. After this activity participants will be able to better identify, diagnose, and manage patients’ substance use disorders and will routinely follow up-to-date evidence-based guidelines on how to best identify, diagnose, and manage patients’ substance use disorders.